sulfinpyrazone has been researched along with Centriacinar Emphysema in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Excerpt | Relevance | Reference |
---|---|---|
" None of the drugs inhibited chemotaxis in a dose-response fashion at concentrations achievable in human plasma." | 1.28 | Search for drugs that may reduce the load of neutrophil azurophilic granule enzymes in the lungs of patients with emphysema. ( Cohen, AB; Miller, EJ; Stevens, MD, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keller, R | 1 |
Stevens, MD | 1 |
Miller, EJ | 1 |
Cohen, AB | 1 |
1 review available for sulfinpyrazone and Centriacinar Emphysema
Article | Year |
---|---|
[Adult respiratory distress syndrome (ARDS) (author's transl)].
Topics: Adrenal Cortex Hormones; Alkalosis; Barotrauma; Humans; Hypoxia; Myocardial Infarction; Positive-Pre | 1981 |
1 other study available for sulfinpyrazone and Centriacinar Emphysema
Article | Year |
---|---|
Search for drugs that may reduce the load of neutrophil azurophilic granule enzymes in the lungs of patients with emphysema.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis; Glucuronidase; Humans | 1989 |